Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
18.20
-0.56 (-2.99%)
Dec 5, 2025, 4:00 PM EST - Market closed
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $997.03 million as of December 5, 2025. Its market cap has decreased by -5.16% in one year.
Market Cap
997.03M
Enterprise Value
708.84M
1-Year Change
-5.16%
Ranking
Category
Stock Price
$18.20
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $997.03M, an increase of 7.01%. That is a compound annual growth rate of 5.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 997.03M | 5.18% |
| Dec 31, 2024 | 947.92M | 1.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |